Inflexxion® offers a comprehensive array of pharmaceutical risk management programs and consulting services to companies that develop and market opioids and stimulants.
Our services help pharmaceutical companies meet the FDA’s risk management requirements.
We design and develop scientifically based and empirically validated offerings that:
- Aid pharmaceutical companies in helping consumers use prescription drugs safely.
- Assist with surveillance of prescription opioids and other therapeutic agents.
- Include educational programs tailored toward specific populations and are designed to complement professional treatment programs.
Inflexxion helps pharmaceutical and biotechnology companies to develop risk evaluation and mitigation strategies (REMS) for their products, in light of increasing drug abuse and misuse. more...
The National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO) is the premier risk management program for prescription opioids, stimulants and other selected therapeutic agents. more...